- Tags: covid19 testing abbott akamanta
- Categories: Tech
By peter g. evans | March 28, 2020 | United States
Go inside molecular testing and see how ID NOW works. Abbott has received emergency use authorization (EUA) from the U.S. Food and Drug Administration (FDA) for the fastest available molecular point-of-care test for the detection of novel coronavirus (COVID-19), delivering positive results in as little as five minutes and negative results in 13 minutes. That’s #LifeToTheFullest.